C9orf72 and frontotemporal dementia: Some 20% of ALS cases, mostly bearing the C9orf72 hexanucleotide repeat extension, develop frontotemporal lobar degeneration (FTLD) and progressive cognitive decline with behavioural changes subsequently leading to clinical frontotemporal dementia (FTD) [2].